Traws Pharma, Inc. — Director's Dealing 2013

Jul 25, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	644660	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Convertible Preferred Stock	$		Common Stock (99350)		Indirect
Series C Convertible Preferred Stock	$		Common Stock (140449)		Indirect
Series D Convertible Preferred Stock	$		Common Stock (355528)		Indirect
Series E Convertible Preferred Stock	$		Common Stock (634625)		Indirect
Series F Convertible Preferred Stock	$		Common Stock (111227)		Indirect
Series F Convertible Preferred Stock	$		Common Stock (109653)		Indirect
Series G Convertible Preferred Stock	$		Common Stock (229825)		Indirect
Series H Convertible Preferred Stock	$		Common Stock (301290)		Indirect
Series I Convertible Preferred Stock	$		Common Stock (1635514)		Indirect
Stock Option (right to purchase)	$2.67	2016-04-01	Common Stock (18754)		Direct
Stock Option (right to purchase)	$6.00	2017-10-04	Common Stock (56264)		Direct
Stock Option (right to purchase)	$5.76	2020-03-17	Common Stock (52513)		Direct
Stock Option (right to purchase)	$6.13	2021-04-18	Common Stock (18754)		Direct
Stock Option (right to purchase)	$6.13	2021-12-05	Common Stock (18754)		Direct
Stock Option (right to purchase)	$13.28	2023-01-02	Common Stock (37509)		Direct

Footnotes

F1: These shares are held in a trust for the benefit of the reporting person's descendents. The reporting person's spouse is a trustee of the trust.

F2: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.85-for-1 basis and has no expiration date.

F3: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F4: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F5: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F6: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.77-for-1 basis and has no expiration date.

F7: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F8: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F9: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.